| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Paula Rochon | Q42384149 |
| Susan E Bronskill | Q89428603 | ||
| P2093 | author name string | Sudeep S Gill | |
| Morris Freedman | |||
| Philip E Lee | |||
| Michael P Hillmer | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
| Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group | Q28371928 | ||
| Systematic reviews in health care: Assessing the quality of controlled clinical trials | Q29618659 | ||
| Impact of legislation on nursing home care in the United States: lessons for the United Kingdom | Q33798248 | ||
| National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology | Q34104531 | ||
| Movement disorders associated with neuroleptic treatment. | Q34390135 | ||
| Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia | Q34390142 | ||
| Long-term safety of risperidone. | Q34390151 | ||
| Tardive dyskinesias in the elderly | Q34465779 | ||
| Metabolic side effects of antipsychotics: focus on hyperglycemia and diabetes. | Q34576884 | ||
| A metaanalysis of controlled trials of neuroleptic treatment in dementia | Q37586446 | ||
| The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia | Q39605807 | ||
| Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. | Q39764934 | ||
| Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents | Q40623224 | ||
| Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations | Q40802281 | ||
| Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients | Q41671806 | ||
| A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients | Q43827150 | ||
| Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia | Q43827160 | ||
| Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia. | Q43942941 | ||
| Use of psychoactive medication and the quality of care in rest homes. Findings and policy implications of a statewide study | Q44079554 | ||
| Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics | Q44299750 | ||
| A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. | Q44359598 | ||
| Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study | Q46193667 | ||
| A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. | Q51981345 | ||
| A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. | Q52042533 | ||
| Factors determining the decision to institutionalize dementing individuals: a prospective study. | Q52060014 | ||
| A rating scale for extrapyramidal side effects | Q53780342 | ||
| Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's Disease Cooperative Study | Q57279010 | ||
| A 1-year follow-up study of behavioral and psychological symptoms in dementia among people in care environments | Q57813994 | ||
| Neuroleptic Drug Therapy in Older Adults Newly Admitted to Nursing Homes: Incidence, Dose, and Specialist Contact | Q58070877 | ||
| Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group | Q73031772 | ||
| A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementia | Q74815220 | ||
| P433 | issue | 7457 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 75 | |
| P577 | publication date | 2004-06-11 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review | |
| P478 | volume | 329 |
| Q36403620 | A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia |
| Q37668243 | A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors |
| Q36003456 | Aggression in persons with dementia: use of nursing theory to guide clinical practice |
| Q42365064 | All drugs can have serious side effects |
| Q37151230 | Alternatives to atypical antipsychotics for the management of dementia-related agitation. |
| Q64109808 | Anticholinergic medicines use among older adults before and after initiating dementia medicines |
| Q90680251 | Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects |
| Q33248004 | Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study |
| Q36295231 | Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events |
| Q89964184 | Are Anticholinergic Medications Associated With Increased Risk of Dementia and Behavioral and Psychological Symptoms of Dementia? A Nationwide 15-Year Follow-Up Cohort Study in Taiwan |
| Q33869831 | Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study |
| Q38850666 | Atypical antipsychotics and effects on feeding: from mice to men. |
| Q21260276 | Atypical antipsychotics in bipolar disorder: systematic review of randomised trials |
| Q37166113 | Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia |
| Q36492352 | Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer's disease: risks or benefits |
| Q90266788 | Baseline imbalances and clinical outcomes of atypical antipsychotics in dementia: A meta-epidemiological study of randomized trials |
| Q36367088 | Behavioural and psychological symptoms of dementia in primary care: a survey of general practitioners in Ireland. |
| Q26865397 | Challenge of changing nursing home prescribing culture |
| Q46705983 | Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia |
| Q37108146 | Current therapeutic options for Alzheimer's disease |
| Q46978338 | Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia |
| Q34558884 | Dementia prevention, intervention, and care. |
| Q36787352 | Dementia syndromes: evaluation and treatment |
| Q33984910 | Do atypical antipsychotics cause stroke? |
| Q41658442 | Educational disparities in antipsychotic drug use among older people with and without dementia in Sweden |
| Q36194233 | Effect of Psychotropic Drugs on Development of Diabetes Mellitus in Patients With Alzheimer's Disease |
| Q37456189 | Effectiveness of Caregiver Interventions on Patient Outcomes in Adults With Dementia or Alzheimer's Disease: A Systematic Review |
| Q51900623 | Ethical questions in the treatment of subjects with dementia. Part I. Respecting autonomy: awareness, competence and behavioural disorders. |
| Q36408852 | Guidelines for the treatment of Alzheimer's disease from the Italian Association of Psychogeriatrics |
| Q50656271 | Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice. |
| Q42928265 | Increased mortality among elderly patients with dementia using atypical antipsychotics |
| Q26739029 | Longitudinal course of behavioural and psychological symptoms of dementia: systematic review |
| Q37069043 | Management of the behavioral and psychological symptoms of dementia |
| Q53483654 | NEURODEM: assessment of the iatrogenic alert indicator for nursing home patients with Alzheimer's or Alzheimer-like disease. |
| Q36310524 | NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease |
| Q46421706 | Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: risks of cerebrovascular events. A controlled, open-label study. |
| Q43122181 | Patterns of antipsychotic medication use in Australia 2002-2007. |
| Q36479867 | Pharmacological treatment of Alzheimer's Disease |
| Q46938737 | Physicians' practice and familiarity with treatment for agitation associated with dementia in Israeli nursing homes |
| Q26782490 | Potential drug-drug interactions in Alzheimer patients with behavioral symptoms |
| Q60308321 | Prescribing and testing by primary care providers to assess adherence to the Choosing Wisely Canada recommendations: a retrospective cohort study |
| Q37837997 | Prescribing for older people in nursing homes: a review of the key issues |
| Q36761466 | Prescribing of Psychoactive Drugs for Older People in Nursing Homes: An Analysis of Treatment Culture |
| Q37219314 | Prescribing of psychotropic medications to the elderly population of a Canadian province: a retrospective study using administrative databases |
| Q51003923 | Prescribing pattern of psychotropic drugs in nursing home residents with dementia. |
| Q46897348 | Prescription patterns and efficacy of drugs for patients with dementia: physicians' perspective in Italy |
| Q43065189 | Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara |
| Q91318424 | Psychotropic prescribing in the oldest old attending a geriatric psychiatry service: a retrospective, cross-sectional study |
| Q33483929 | Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006. |
| Q64924954 | Risk Evaluation for Antipsychotic Agents Used in Elderly Inpatients (REPAIR). |
| Q33736204 | Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study. |
| Q38257153 | Risperidone and pulmonary embolism: a harmful association? Case series and review of the literature |
| Q36655157 | Risperidone for the treatment of neuropsychiatric features in dementia. |
| Q33641585 | Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials |
| Q93040652 | Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia |
| Q47642128 | The Black Book of Psychotropic Dosing and Monitoring |
| Q64891767 | The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia. |
| Q47918037 | The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease |
| Q87422997 | The effects of public reporting on physical restraints and antipsychotic use in nursing home residents with severe cognitive impairment |
| Q36272515 | The impact of European regulatory policies on psychotropic drug prescribing patterns |
| Q33480648 | Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. |
| Q51984955 | [Medication and memory: interactions among the elderly]. |
| Q84577559 | [Polypharmacy and falls in the Elderly] |
| Q81361878 | [The benefits and risks of medicines] |
Search more.